Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.

Oral diseases - 1 May 1997

White T C, Pfaller M A, Rinaldi M G, Smith J, Redding S W

Abstract excerpt

Oral candidiasis is one of the earliest and most frequent complications of a failing immune system in HIV-infected individuals. For several years, oral candidiasis has been treated effectively with azole drugs, the one most frequently used is fluconazole. Unfortunately, extensive use of the drug for treatment and prophylaxis has led to treatment failure in an increasing number of patients. In most of these cases,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida albicans
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Heterogeneity

Share to HIV Infections

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Phenotype

Source

Identifiers

PMID: 9456667
DOI: 10.1111/j.1601-0825.1997.tb00336.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.PMID 9456667Read ↗

Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosisSemantic proximity Read ↗

Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretroviral therapy.Semantic proximity Read ↗

Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.Semantic proximity Read ↗

Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.Semantic proximity Read ↗

Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.Semantic proximity Read ↗

Marked virulence and azole resistance in Candida albicans isolated from patients with periodontal diseaseSemantic proximity Read ↗

Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.Semantic proximity Read ↗

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersSemantic proximity Read ↗

Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.Semantic proximity Read ↗

Rapid, Transient Fluconazole Resistance in <i>Candida albicans</i> Is Associated with Increased mRNA Levels of <i>CDR</i>Semantic proximity Read ↗

Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with VirulenceSemantic proximity Read ↗

Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.